2''-METHYL-5''-(TRIFLUOROMETHYL)ACETOPHENONE
- $100 - $491
- Product name: 2''-METHYL-5''-(TRIFLUOROMETHYL)ACETOPHENONE
- CAS: 725743-50-0
- MF: C10H9F3O
- MW: 202.17
- EINECS:
- MDL Number:MFCD09832290
- Synonyms:2''-METHYL-5''-(TRIFLUOROMETHYL)ACETOPHENONE;1-(2-methyl-5‐(trifluoromethyl)phenyl)ethan‐1‐one;Ethanone, 1-[2-methyl-5-(trifluoromethyl)phenyl]-;1-(2-Methyl-5-(trifluoromethyl)phenyl)ethanone
4 prices
Selected condition:
Brand
- AHH
- Crysdot
- SynQuest Laboratories
Package
- 1g
- 5G
- 10g
- ManufacturerAHH
- Product numberMB-22193
- Product description2\-METHYL-5\-(TRIFLUOROMETHYL)ACETOPHENONE 97%
- Packaging1g
- Price$100
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12039328
- Product description1-(2-Methyl-5-(trifluoromethyl)phenyl)ethanone 95+%
- Packaging10g
- Price$491
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number2817-3-21
- Product description2'-Methyl-5'-(trifluoromethyl)acetophenone
- Packaging5G
- Price$199
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number2817-3-21
- Product description2'-Methyl-5'-(trifluoromethyl)acetophenone
- Packaging10g
- Price$360
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AHH | MB-22193 | 2\-METHYL-5\-(TRIFLUOROMETHYL)ACETOPHENONE 97% | 1g | $100 | 2021-12-16 | Buy |
Crysdot | CD12039328 | 1-(2-Methyl-5-(trifluoromethyl)phenyl)ethanone 95+% | 10g | $491 | 2021-12-16 | Buy |
SynQuest Laboratories | 2817-3-21 | 2'-Methyl-5'-(trifluoromethyl)acetophenone | 5G | $199 | 2021-12-16 | Buy |
SynQuest Laboratories | 2817-3-21 | 2'-Methyl-5'-(trifluoromethyl)acetophenone | 10g | $360 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|